Results 341 to 350 of about 961,893 (364)

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Fibroblast Growth Factor 23 and CKD Prognosis

American Journal of Kidney Diseases, 2012
Andrew S. Levey, Navdeep Tangri
openaire   +3 more sources

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Fibroblast Growth Factor 23

Der Nephrologe, 2008
openaire   +2 more sources

The Role of Fibroblast Growth Factor 23 in Sepsis

Critical Care Medicine, 2014
Patompong Ungprasert, Wonngarm Kittanamongkolchai, Narat Srivali   +2 more
openaire   +3 more sources

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Ciara C O’sullivan, Grace D Cullen, Grace M Choong   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Barata, Brian I Rini
exaly  

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

Ca-A Cancer Journal for Clinicians, 2018
Farhad Islami, Ann Goding Sauer, Kimberly D Miller   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Joyce Slingerland, Manuel Picon-ruiz, Cynthia Morata-tarifa   +2 more
exaly